Invenomic Capital Management LP 13D and 13G filings for Lexaria Bioscience Corp.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 4:11 pm Sale |
2024-02-22 | 13G | Lexaria Bioscience Corp. LEXX |
Invenomic Capital Management LP | 567,650 4.700% |
-164,331 (-22.45%) |
Filing |
| 2024-02-14 12:00 pm Purchase |
2023-12-31 | 13G | Lexaria Bioscience Corp. LEXX |
Invenomic Capital Management LP | 731,981 7.120% |
258,878 (+54.72%) |
Filing |
| 2023-02-10 4:06 pm Purchase |
2022-12-31 | 13G | Lexaria Bioscience Corp. LEXX |
Invenomic Capital Management LP | 473,103 7.950% |
113,990 (+31.74%) |
Filing |
| 2022-02-11 5:33 pm Purchase |
2021-12-31 | 13G | Lexaria Bioscience Corp. LEXX |
Invenomic Capital Management LP | 359,113 6.030% |
359,113 (New Position) |
Filing |